These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36105211)

  • 1. Identification of a potential diagnostic signature for postmenopausal osteoporosis
    Zeng R; Ke TC; Ou MT; Duan LL; Li Y; Chen ZJ; Xing ZB; Fu XC; Huang CY; Wang J
    Front Pharmacol; 2022; 13():944735. PubMed ID: 36105211
    [No Abstract]   [Full Text] [Related]  

  • 2. Analysis and validation of biomarkers of immune cell-related genes in postmenopausal osteoporosis: An observational study.
    Chen L; Zhao Y; Qiu J; Lin X
    Medicine (Baltimore); 2024 May; 103(19):e38042. PubMed ID: 38728482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a potential signature to predict the risk of postmenopausal osteoporosis.
    Geng Y; Shao R; Xu T; Zhang L
    Gene; 2024 Feb; 894():147942. PubMed ID: 37935322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Serum Exosome-Derived circRNA-miRNA-TF-mRNA Regulatory Network in Postmenopausal Osteoporosis Using Bioinformatics Analysis and Validation in Peripheral Blood-Derived Mononuclear Cells.
    Dong Q; Han Z; Tian L
    Front Endocrinol (Lausanne); 2022; 13():899503. PubMed ID: 35757392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of ROCK1 as a novel biomarker for postmenopausal osteoporosis and pan-cancer analysis.
    Lai B; Jiang H; Gao Y; Zhou X
    Aging (Albany NY); 2023 Sep; 15(17):8873-8907. PubMed ID: 37683138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a gene signature predicting the risk of postmenopausal osteoporosis.
    Yuan W; Yang M; Zhu Y
    Bone Joint Res; 2022 Aug; 11(8):548-560. PubMed ID: 35920104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analysis of the m6A-related molecular patterns and diagnostic biomarkers in osteoporosis.
    Bai Q; Shi M; Sun X; Lou Q; Peng H; Qu Z; Fan J; Dai L
    Front Endocrinol (Lausanne); 2022; 13():957742. PubMed ID: 36034449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Machine learning algorithms assisted identification of post-stroke depression associated biological features.
    Zhang X; Wang X; Wang S; Zhang Y; Wang Z; Yang Q; Wang S; Cao R; Yu B; Zheng Y; Dang Y
    Front Neurosci; 2023; 17():1146620. PubMed ID: 36968495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated single-cell and bulk RNA sequencing analysis reveal immune-related biomarkers in postmenopausal osteoporosis.
    Fang S; Ni H; Zhang Q; Dai J; He S; Min J; Zhang W; Li H
    Heliyon; 2024 Sep; 10(18):e38022. PubMed ID: 39328516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioinformatics identification and experimental validation of m6A-related diagnostic biomarkers in the subtype classification of blood monocytes from postmenopausal osteoporosis patients.
    Zhang P; Chen H; Xie B; Zhao W; Shang Q; He J; Shen G; Yu X; Zhang Z; Zhu G; Chen G; Yu F; Liang D; Tang J; Cui J; Liu Z; Ren H; Jiang X
    Front Endocrinol (Lausanne); 2023; 14():990078. PubMed ID: 36967763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential diagnostic value of PD-1 in peripheral blood mononuclear cells of postmenopausal osteoporosis patients.
    Cai XP; Zhao Q; Guo ZD; Lin SJ; Chen ZX; Chen MY; Zheng L; Zhao KW
    J Clin Lab Anal; 2020 Jun; 34(6):e23223. PubMed ID: 32065479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feature selection approaches identify potential plasma metabolites in postmenopausal osteoporosis patients.
    Wang J; Wang Y; Zeng Y; Huang D
    Metabolomics; 2022 Nov; 18(11):86. PubMed ID: 36318345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of potential M2 macrophage-associated diagnostic biomarkers in coronary artery disease.
    Li K; Kong R; Ma L; Cao Y; Li W; Chen R; Gong K; Jiang L
    Biosci Rep; 2022 Dec; 42(12):. PubMed ID: 36222281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of gene biomarkers in patients with postmenopausal osteoporosis.
    Yang C; Ren J; Li B; Jin C; Ma C; Cheng C; Sun Y; Shi X
    Mol Med Rep; 2019 Feb; 19(2):1065-1073. PubMed ID: 30569177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Integrated Model Based on a Six-Gene Signature Predicts Overall Survival in Patients With Hepatocellular Carcinoma.
    Li W; Lu J; Ma Z; Zhao J; Liu J
    Front Genet; 2019; 10():1323. PubMed ID: 32010188
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification of biomarkers associated with diagnosis of postmenopausal osteoporosis patients based on bioinformatics and machine learning.
    Huang X; Ma J; Wei Y; Chen H; Chu W
    Front Genet; 2023; 14():1198417. PubMed ID: 37465165
    [No Abstract]   [Full Text] [Related]  

  • 17. Immune-related gene signature to predict TACE refractoriness in patients with hepatocellular carcinoma based on artificial neural network.
    Xu Q; Wang C; Yin G
    Front Genet; 2022; 13():993509. PubMed ID: 36685822
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of ferroptosis-associated biomarkers for the potential diagnosis and treatment of postmenopausal osteoporosis.
    Hu Y; Han J; Ding S; Liu S; Wang H
    Front Endocrinol (Lausanne); 2022; 13():986384. PubMed ID: 36105394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic analysis and validation of diagnostic marker genes in patients with osteoporosis.
    Wang X; Pei Z; Hao T; Ariben J; Li S; He W; Kong X; Chang J; Zhao Z; Zhang B
    Front Immunol; 2022; 13():987937. PubMed ID: 36311708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioinformatics analysis of gene expression profiles in B cells of postmenopausal osteoporosis patients.
    Ma M; Luo S; Zhou W; Lu L; Cai J; Yuan F; Yin F
    Taiwan J Obstet Gynecol; 2017 Apr; 56(2):165-170. PubMed ID: 28420501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.